Micotherapy Linfo
Micotherapy LINFO è un integratore che sfrutta la sinergia della micoterapia con il fungo Polyporus umbellatus, con la rapidità di azione delle componenti fitoterapiche quali Centella asiatica, Bromelina e Meliloto, correttamente titolate, utili in caso di ritenzione di liquidi, edema tissutale, sensazione di gonfiore alle mani e agli arti inferiori, per favorire una corretta eliminazione tossinica attraverso il sistema linfatico
Formato
90 capsule
Mdo d'uso
2 capsule 2 volte al giorno, preferibilmente lontano dai pasti
Proprietà
Micotherapy LINFO è un integratore appositamente formulato per favorire la corretta funzionalità del sistema linfatico e venoso, favorendo la riduzione dell’infiammazione cronica, spesso alla base della formazione di edema tissutale generalizzato e della stasi delle tosside a livello dell’edema. L’integrazione con Micotherapy LINFO si rivela utile per sostenere il sistema linfatico, in caso di ritenzione idrica diffusa o localizzata (Cellulite), sensazione di pesantezza o gonfiore agli arti inferiori, edemi e insufficienza veno-linfatica. Inoltre, la sinergia Centella - Polyporus coadiuva le fisiologiche funzioni del sistema glinfatico cerebrale, permettendo di migliorare situazioni di confusione mentale (Brain-fog) e di ridurre le difficoltà di concentrazione.
Effetti principali
Coadiuva la corretta funzionalità del microcircolo e l’equilibrio dei liquidi corporei. Utile in caso di edemi, ritenzione idrica, cellulite e pesantezza agli arti inferiori
Informazioni nutrizionali
| Componenti |
Per dosaggio giornaliero |
|---|---|
| Polyporus umbellatus sporophorum | 1188 mg |
| Centella estr. secco | 235 mg |
| Apporto asiaticoside | 94 mg |
| Bromelina | 198 mg |
| Meliloto estratto secco | 153 mg |
| Apporto di cumarine | 30 mg |
Reperibilità prodotto
Codice parafarmaco: A923582136
Inserito nel registro degli integratori n°: codice 62491
Note:
Yuan D et al. An anti-aldosteronic diuretic component (drain dampness) in Polyporus sclerotium. Biol Pharm Bull. 2004 27(6):867-70
Zhang G et al. Diuretic activity and kidney medulla AQP1, AQP2, AQP3, V2R expression of the aqueous extract of sclerotia of Polyporus umbellatus FRIES in normal rats. Journal of Ethnopharmacology 128 (2010) 433–437
Zhao Y.Y et al. Bioactivity-directed isolation, identification of diuretic compounds from Polyporus umbellatus. J Ethnopharmacol. 2009;126(1):184-7
Zhang GW et al. Efficacy of Zhuling polyporus polysaccharide with BCG to inhibit bladder carcinoma. Carbohydr Polym. 2015 Mar 15; 118:30-5.
Zhao YY. Traditional uses, phytochemistry, pharmacology, pharmacokinetics and quality control of Polyporus umbellatus (Pers) Fries: a review. J Ethnopharmacol. 2013 Aug 26;149(1):35-48.
Li X, Xu W. TLR4-mediated activation of macrophages by the polysaccharide fraction from Polyporus umbellatus(pers) Fries. J Ethnopharmacol. 2011 Apr 26;135(1):1-6.
Zhang G et al. Inhibition of urinary bladder carcinogenesis by aqueous extract of sclerotia of Polyporus umbellatus fries and polyporus polysaccharide. Am J Chin Med. 2011;39(1):135-44.
Zhao YY etal. Quantitative HPLC method and pharmacokinetic studies of ergosta-4,6,8(14),22-tetraen-3-one, a natural product with diuretic activity from Polyporus umbellatus. Biomed Chromatogr. 2010 Oct;24(10):1120-4.
Incandela L, Cesarone MR, Cacchio M, De Sanctis MT, Santavenere C, D’Auro MG, Bucci M, Belcaro G. Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. Angiology. 2001 Oct; 52 Suppl 2:S9-13)
Sulistyowati E et al., Vasculoprotective effects of Centella asiatica, Justicia gendarussa and Imperata cylindrica decoction via the NOXs-ROS-NF-kappaB pathway in spontaneously hypertensive rats. J Tradit Complement Med. 2019 Jun 24;10(4):378-388.
Cesarone MR et al.The microcirculatory activity of Centella asiatica in venous insufficiency. A double-blind study. Minerva Cardioangiol 1994; 42: 299-304).
Incandela L et al. Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. Angiology. 2001 Oct; 52 Suppl 2:S61-7).
Chong NJ and Aziz Z. A Systematic Review of the Efficacy of Centella asiatica for Improvement of the Signs and Symptoms of Chronic Venous Insufficiency. Evid Based Complement Alternat Med. 2013;2013:627182.
Montecchio GP, Samaden A, Carbone S, Vigotti M, Siragusa S, Piovella F. Centella Asiatica Triterpenic Fraction (CATTF) reduces the number of circulating endothelial cells in subjects with post phlebitic syndrome. Haematologica 1991; 76: 256-9).
De Sanctis MT et al., Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: a clinical, prospective, placebo-controlled, randomized, dose-ranging trial. Angiology. 2001 Oct;52 Suppl 2:S55-9.
Azarkan M et al. Stem Bromelain Proteolytic Machinery: Study of the Effects of its Components on Fibrin (ogen) and Blood Coagulation. Protein Pept Lett. 2020;27(11):1159-1170.
Walker AF et al. Bundy R, Hicks SM, Middleton RW. Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adults. Phytomedicine 2002;9:681-6.
Taussig SJ and Batkin S. Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. An update. J Ethnopharmacol 1988;22:191-203.
Stone MB, Merrick MA, Ingersoll CD, et al. Preliminary comparison of bromelain and Ibuprofen for delayed onset muscle soreness management. Clin J Sport Med 2002;12:373-8.
Bernela M et al. Enhancement of anti-inflammatory activity of bromelain by its encapsulation in katira gum nanoparticles. Carbohydr Polym. 2016 Jun 5;143:18-24
Dutta S and Bhattacharyya D. Enzymatic, antimicrobial and toxicity studies of the aqueous extract of Ananas comosus (pineapple) crown leaf. .J Ethnopharmacol. 2013 Nov 25;150(2):451-7.
MacKay D and Miller AL. Nutritional support for wound healing. Altern Med Rev. 2003 Nov;8(4):359-77.
Lotz-Winter H. On the pharmacology of bromelain: an update with special regard to animal studies on dose-dependent effects. Planta Med. 1990 Jun;56(3):249-53.
Paun G. et al. In Vitro Evaluation of Antidiabetic and Anti-Inflammatory Activities of Polyphenolic-Rich Extracts from Anchusa officinalis and Melilotus officinalis. ACS Omega. 2020 May 22;5(22):13014-13022.
Saleem M et al., Investigation of in vivo anti-inflammatory and anti-angiogenic attributes of coumarin-rich ethanolic extract of Melilotus indicus. Inflammopharmacology. 2020 Apr 15.
Asres K. Et al. Anti-inflammatory activity of extracts and a saponin isolated from Melilotus elegans. Pharmazie. 2005 Apr;60(4):310-2.
Consoli A. [Chronic venous insufficiency: an open trial of FLEBS Crema]. Minerva Cardioangiol. 2003 Aug;51(4):411-6.
Cataldi A et al. [Effectiveness of the combination of alpha tocopherol, rutin, melilotus, and centella asiatica in the treatment of patients with chronic venous insufficiency]. Minerva Cardioangiol. 2001 Apr;49(2):159-63.
Linee prodotti
